A citation-based method for searching scientific literature

Xing Hua, Lina Yu, Xiaoxiao Huang, Zexiao Liao, Qi Xian. Diagn Pathol 2011
Times Cited: 27







List of co-cited articles
259 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis.
Maria L Wikberg, Sofia Edin, Ida V Lundberg, Bethany Van Guelpen, Anna M Dahlin, Jörgen Rutegård, Roger Stenling, Ake Oberg, Richard Palmqvist. Tumour Biol 2013
97
33

Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance.
Min Shi, Dang-Hui Yu, Ying Chen, Chen-Yan Zhao, Jing Zhang, Qing-Hua Liu, Can-Rong Ni, Ming-Hua Zhu. World J Gastroenterol 2012
90
29

Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha.
Matthew Kraman, Paul J Bambrough, James N Arnold, Edward W Roberts, Lukasz Magiera, James O Jones, Aarthi Gopinathan, David A Tuveson, Douglas T Fearon. Science 2010
748
25

Fibroblast activation protein: A potential therapeutic target in cancer.
Rui Liu, Hui Li, Liang Liu, Jinpu Yu, Xiubao Ren. Cancer Biol Ther 2012
91
22

Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma.
Steven J Cohen, R Katherine Alpaugh, Irma Palazzo, Neal J Meropol, André Rogatko, Zhiheng Xu, John P Hoffman, Louis M Weiner, Jonathan D Cheng. Pancreas 2008
156
22

Clinical implications of fibroblast activation protein in patients with colon cancer.
Leonard R Henry, Hyung-Ok Lee, John S Lee, Andres Klein-Szanto, Perry Watts, Eric A Ross, Wen-Tien Chen, Jonathan D Cheng. Clin Cancer Res 2007
232
18

FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells.
Hyung-Ok Lee, Stefanie R Mullins, Janusz Franco-Barraza, Matthildi Valianou, Edna Cukierman, Jonathan D Cheng. BMC Cancer 2011
180
18

Fibroblasts in cancer.
Raghu Kalluri, Michael Zeisberg. Nat Rev Cancer 2006
18

Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.
Angélica M Santos, Jason Jung, Nazneen Aziz, Joseph L Kissil, Ellen Puré. J Clin Invest 2009
287
18

Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake.
Markus Loeffler, Jörg A Krüger, Andreas G Niethammer, Ralph A Reisfeld. J Clin Invest 2006
419
18

Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions.
Yan Huang, Avis E Simms, Anna Mazur, Sophie Wang, Noel R León, Barry Jones, Nazneen Aziz, Thomas Kelly. Clin Exp Metastasis 2011
68
18

Radioimmunotherapy of fibroblast activation protein positive tumors by rapidly internalizing antibodies.
Eliane Fischer, Krishna Chaitanya, Thomas Wüest, Andreas Wadle, Andrew M Scott, Maries van den Broek, Roger Schibli, Stefan Bauer, Christoph Renner. Clin Cancer Res 2012
55
18


The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer.
Roy M Bremnes, Tom Dønnem, Samer Al-Saad, Khalid Al-Shibli, Sigve Andersen, Rafael Sirera, Carlos Camps, Inigo Marinez, Lill-Tove Busund. J Thorac Oncol 2011
382
14

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.
Akira Orimo, Piyush B Gupta, Dennis C Sgroi, Fernando Arenzana-Seisdedos, Thierry Delaunay, Rizwan Naeem, Vincent J Carey, Andrea L Richardson, Robert A Weinberg. Cell 2005
14

Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas.
Keisuke Kurose, Kristie Gilley, Satoshi Matsumoto, Peter H Watson, Xiao-Ping Zhou, Charis Eng. Nat Genet 2002
342
14

Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV.
Victoria J Christiansen, Kenneth W Jackson, Kyung N Lee, Patrick A McKee. Arch Biochem Biophys 2007
75
14

Breast-cancer stromal cells with TP53 mutations and nodal metastases.
Attila Patocs, Li Zhang, Yaomin Xu, Frank Weber, Trinidad Caldes, George L Mutter, Petra Platzer, Charis Eng. N Engl J Med 2007
242
14

PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment.
Yongping Crawford, Ian Kasman, Lanlan Yu, Cuiling Zhong, Xiumin Wu, Zora Modrusan, Josh Kaminker, Napoleone Ferrara. Cancer Cell 2009
427
14

Molecular biology of cancer-associated fibroblasts: can these cells be targeted in anti-cancer therapy?
Tamas A Gonda, Andrea Varro, Timothy C Wang, Benjamin Tycko. Semin Cell Dev Biol 2010
111
14

Cancer associated fibroblasts in cancer pathogenesis.
Omar E Franco, Aubie K Shaw, Douglas W Strand, Simon W Hayward. Semin Cell Dev Biol 2010
262
14

Cancer associated fibroblasts (CAFs) in tumor microenvironment.
Fei Xing, Jamila Saidou, Kounosuke Watabe. Front Biosci (Landmark Ed) 2010
401
14

Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein.
Kyung N Lee, Kenneth W Jackson, Victoria J Christiansen, Chung S Lee, Jin-Geun Chun, Patrick A McKee. Blood 2006
118
14

Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes.
Stefan Bauer, Michael C Jendro, Andreas Wadle, Sascha Kleber, Frank Stenner, Robert Dinser, Anja Reich, Erica Faccin, Stefan Gödde, Harald Dinges,[...]. Arthritis Res Ther 2006
131
14

Expression and role of the cell surface protease seprase/fibroblast activation protein-α (FAP-α) in astroglial tumors.
Rolf Mentlein, Kirsten Hattermann, Charles Hemion, Achim A Jungbluth, Janka Held-Feindt. Biol Chem 2011
45
14

Expression of the fibroblast activation protein during mouse embryo development.
J Niedermeyer, P Garin-Chesa, M Kriz, F Hilberg, E Mueller, U Bamberger, W J Rettig, A Schnapp. Int J Dev Biol 2001
58
14


The expression of a type II transmembrane serine protease (Seprase) in human gastric carcinoma.
Yoshiyuki Mori, Koji Kono, Yoshirou Matsumoto, Hideki Fujii, Tetsu Yamane, Masako Mitsumata, Wen-Tien Chen. Oncology 2004
55
14

Fibroblast activation protein-α promotes ovarian cancer cell proliferation and invasion via extracellular and intracellular signaling mechanisms.
WeiWei Yang, Wei Han, ShengQian Ye, DuanYang Liu, Jun Wu, HongYu Liu, ChunHong Li, He Chen. Exp Mol Pathol 2013
32
14

Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression.
Masayuki Shimoda, Kieran T Mellody, Akira Orimo. Semin Cell Dev Biol 2010
244
14

Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites.
Saurabh Aggarwal, W Nathaniel Brennen, Thomas P Kole, Elizabeth Schneider, Ozlem Topaloglu, Melinda Yates, Robert J Cotter, Samuel R Denmeade. Biochemistry 2008
60
14


Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors.
Margit A Huber, Norbert Kraut, John E Park, Roland D Schubert, Wolfgang J Rettig, Ralf U Peter, Pilar Garin-Chesa. J Invest Dermatol 2003
116
14

Fibroblast activation protein-α: a key modulator of the microenvironment in multiple pathologies.
Thomas Kelly, Yan Huang, Avis E Simms, Anna Mazur. Int Rev Cell Mol Biol 2012
77
14

Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma.
H Wang, Q Wu, Z Liu, X Luo, Y Fan, Y Liu, Y Zhang, S Hua, Q Fu, M Zhao,[...]. Cell Death Dis 2014
110
14

c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma.
M Tokunou, T Niki, K Eguchi, S Iba, H Tsuda, T Yamada, Y Matsuno, H Kondo, Y Saitoh, H Imamura,[...]. Am J Pathol 2001
98
11

The fibroblast: sentinel cell and local immune modulator in tumor tissue.
Tobias Silzle, Gwendalyn J Randolph, Marina Kreutz, Leoni A Kunz-Schughart. Int J Cancer 2004
132
11

Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.
A F Olumi, G D Grossfeld, S W Hayward, P R Carroll, T D Tlsty, G R Cunha. Cancer Res 1999
11

No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas.
Wen Qiu, Min Hu, Anita Sridhar, Ken Opeskin, Stephen Fox, Michail Shipitsin, Melanie Trivett, Ella R Thompson, Manasa Ramakrishna, Kylie L Gorringe,[...]. Nat Genet 2008
218
11

A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.
Andrew M Scott, Greg Wiseman, Sydney Welt, Alex Adjei, Fook-Thean Lee, Wendie Hopkins, Chaitan R Divgi, Lorelei H Hanson, Paul Mitchell, Denise N Gansen,[...]. Clin Cancer Res 2003
261
11

Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts.
Yasushi Kojima, Ahmet Acar, Elinor Ng Eaton, Kieran T Mellody, Christina Scheel, Ittai Ben-Porath, Tamer T Onder, Zhigang C Wang, Andrea L Richardson, Robert A Weinberg,[...]. Proc Natl Acad Sci U S A 2010
535
11


Evaluation of the tumor targeting of a FAPα-based doxorubicin prodrug.
Sichao Huang, Rui Fang, Jun Xu, Shenghong Qiu, Huan Zhang, Jun Du, Shaohui Cai. J Drug Target 2011
38
11

Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer.
Janna Paulsson, Tobias Sjöblom, Patrick Micke, Fredrik Pontén, Göran Landberg, Carl-Henrik Heldin, Jonas Bergh, Donal J Brennan, Karin Jirström, Arne Ostman. Am J Pathol 2009
175
11

VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis.
Jianying Dong, Jeremy Grunstein, Max Tejada, Frank Peale, Gretchen Frantz, Wei-Ching Liang, Wei Bai, Lanlan Yu, Joe Kowalski, Xiaohuan Liang,[...]. EMBO J 2004
230
11

Stromal fibroblasts in cancer initiation and progression.
Neil A Bhowmick, Eric G Neilson, Harold L Moses. Nature 2004
11

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion.
Ravid Straussman, Teppei Morikawa, Kevin Shee, Michal Barzily-Rokni, Zhi Rong Qian, Jinyan Du, Ashli Davis, Margaret M Mongare, Joshua Gould, Dennie T Frederick,[...]. Nature 2012
11

Breast carcinoma-associated fibroblasts rarely contain p53 mutations or chromosomal aberrations.
Abdel Nasser Hosein, Min Wu, Suzanna L Arcand, Sylvie Lavallée, Josée Hébert, Patricia N Tonin, Mark Basik. Cancer Res 2010
61
11


PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism.
Sharlene Adams, Glenn T Miller, Michael I Jesson, Takeshi Watanabe, Barry Jones, Barbara P Wallner. Cancer Res 2004
135
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.